Literature DB >> 34762965

Mammography adherence in relation to function-related indicators in older women.

Dongyu Zhang1, Linn Abraham2, Brian L Sprague3, Tracy Onega4, Shailesh Advani5, Joshua Demb6, Diana L Miglioretti7, Louise M Henderson8, Karen J Wernli2, Louise C Walter9, Karla Kerlikowske10, John T Schousboe11, Elizabeth Chrischilles12, Dejana Braithwaite13, Ellen S O'Meara14.   

Abstract

Prior studies of screening mammography patterns by functional status in older women show inconsistent results. We used Breast Cancer Surveillance Consortium-Medicare linked data (1999-2014) to investigate the association of functional limitations with adherence to screening mammography in 145,478 women aged 66-74 years. Functional limitation was represented by a claims-based function-related indicator (FRI) score which incorporated 16 items reflecting functional status. Baseline adherence was defined as mammography utilization 9-30 months after the index screening mammography. Longitudinal adherence was examined among women adherent at baseline and defined as time from the index mammography to end of the first 30-month gap in mammography. Multivariable logistic regression and Cox proportional hazards models were used to investigate baseline and longitudinal adherence, respectively. Subgroup analyses were conducted by age (66-70 vs. 71-74 years). Overall, 69.6% of participants had no substantial functional limitation (FRI score 0), 23.5% had some substantial limitations (FRI score 1), and 6.8% had serious limitations (FRI score ≥ 2). Mean age at baseline was 68.5 years (SD = 2.6), 85.3% of participants were white, and 77.1% were adherent to screening mammography at baseline. Women with a higher FRI score were more likely to be non-adherent at baseline (FRI ≥ 2 vs. 0: aOR = 1.13, 95% CI = 1.06, 1.20, p-trend < 0.01). Similarly, a higher FRI score was associated with longitudinal non-adherence (FRI ≥ 2 vs. 0: aHR = 1.16, 95% CI = 1.11, 1.22, p-trend < 0.01). Effect measures of FRI did not differ substantially by age categories. Older women with a higher burden of functional limitations are less likely to be adherent to screening mammography recommendations.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer screening; Epidemiology; Functional limitation; Gerontology; Mammography

Mesh:

Year:  2021        PMID: 34762965      PMCID: PMC8724400          DOI: 10.1016/j.ypmed.2021.106869

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  32 in total

1.  Older women, mammography, and mortality from breast cancer.

Authors:  A B Nattinger
Journal:  Am J Med       Date:  2000-02       Impact factor: 4.965

2.  Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.

Authors:  R Ballard-Barbash; S H Taplin; B C Yankaskas; V L Ernster; R D Rosenberg; P A Carney; W E Barlow; B M Geller; K Kerlikowske; B K Edwards; C F Lynch; N Urban; C A Chrvala; C R Key; S P Poplack; J K Worden; L G Kessler
Journal:  AJR Am J Roentgenol       Date:  1997-10       Impact factor: 3.959

3.  Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction.

Authors:  Elizabeth A Chrischilles; Kathleen M Schneider; Mary C Schroeder; Elena Letuchy; Robert B Wallace; Jennifer G Robinson; John M Brooks
Journal:  J Am Geriatr Soc       Date:  2016-03-01       Impact factor: 5.562

4.  Screening mammography for frail older women: what are the burdens?

Authors:  L C Walter; C Eng; K E Covinsky
Journal:  J Gen Intern Med       Date:  2001-11       Impact factor: 5.128

5.  Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors.

Authors:  Thomas P Ahern; Timothy L Lash; Soe Soe Thwin; Rebecca A Silliman
Journal:  Med Care       Date:  2009-01       Impact factor: 2.983

6.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.

Authors:  Kevin C Oeffinger; Elizabeth T H Fontham; Ruth Etzioni; Abbe Herzig; James S Michaelson; Ya-Chen Tina Shih; Louise C Walter; Timothy R Church; Christopher R Flowers; Samuel J LaMonte; Andrew M D Wolf; Carol DeSantis; Joannie Lortet-Tieulent; Kimberly Andrews; Deana Manassaram-Baptiste; Debbie Saslow; Robert A Smith; Otis W Brawley; Richard Wender
Journal:  JAMA       Date:  2015-10-20       Impact factor: 56.272

7.  Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study.

Authors:  Dejana Braithwaite; Dan H Moore; William A Satariano; Marilyn L Kwan; Robert A Hiatt; Candyce Kroenke; Bette J Caan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-09       Impact factor: 4.254

8.  Mammography use in relation to comorbidities and functional limitations among older breast cancer survivors.

Authors:  Dongyu Zhang; Shailesh Advani; Zhikai Zhu; Le Dang; Louise C Walter; Dejana Braithwaite
Journal:  J Cancer Surviv       Date:  2020-07-28       Impact factor: 4.442

9.  Function-related Indicators and Outcomes of Screening Mammography in Older Women: Evidence from the Breast Cancer Surveillance Consortium Cohort.

Authors:  Dongyu Zhang; Linn Abraham; Joshua Demb; Diana L Miglioretti; Shailesh Advani; Brian L Sprague; Louise M Henderson; Tracy Onega; Karen J Wernli; Louise C Walter; Karla Kerlikowske; John T Schousboe; Ellen S O'Meara; Dejana Braithwaite
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-06-02       Impact factor: 4.254

10.  Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer.

Authors:  Dongyu Zhang; Hazel B Nichols; Melissa Troester; Jianwen Cai; Jeannette T Bensen; Dale P Sandler
Journal:  Int J Cancer       Date:  2020-02-04       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.